AstraZeneca PLC (ZEGA) — Cash Flow Reinvestment Rate
AstraZeneca PLC (ZEGA) has a Cash Flow Reinvestment Rate of 0.73x as of September 2025, reinvesting €3.73 Billion (capex €1.73 Billion plus investments €-2.00 Billion) from operating cash flow of €5.13 Billion. Explore AstraZeneca PLC capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
AstraZeneca PLC Cash Flow Reinvestment Rate (2014–2024)
Historical reinvestment intensity for AstraZeneca PLC across 11 annual periods. Also explore balance sheet size of AstraZeneca PLC for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for AstraZeneca PLC (2014–2024)
Year-by-year capital reinvestment analysis for AstraZeneca PLC. For live market cap and broader valuation context, see AstraZeneca PLC market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.06x | €12.57 Billion | €11.86 Billion | €4.59 Billion | ▲ +65.8% |
| 2023 | 0.64x | €6.62 Billion | €10.36 Billion | €3.39 Billion | ▲ +407.9% |
| 2022 | 0.13x | €1.23 Billion | €9.81 Billion | €1.09 Billion | ▼ -55.8% |
| 2021 | 0.28x | €1.70 Billion | €5.96 Billion | €1.09 Billion | ▼ -53.9% |
| 2020 | 0.62x | €2.96 Billion | €4.80 Billion | €961.00 Million | ▲ +65.9% |
| 2019 | 0.37x | €1.10 Billion | €2.97 Billion | €979.00 Million | ▼ -17.7% |
| 2018 | 0.45x | €1.18 Billion | €2.62 Billion | €1.04 Billion | ▼ -8.8% |
| 2017 | 0.50x | €1.77 Billion | €3.58 Billion | €1.33 Billion | ▼ -67.3% |
| 2016 | 1.52x | €6.28 Billion | €4.14 Billion | €2.31 Billion | ▲ +214.5% |
| 2015 | 0.48x | €1.60 Billion | €3.32 Billion | €1.33 Billion | ▲ +204.0% |
| 2014 | 0.16x | €1.12 Billion | €7.06 Billion | €1.01 Billion | — |